Company / Cash per Share
BeOne Medicines Ltd. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.28
FY2025
5-year range
$1.93 / $3.63
FY2021-FY2025
Trend
+69.6%
vs FY2024
Sector context
#63 of 205
Health Care
What the data says
At $3.28, BeOne Medicines Ltd.'s cash per share ranks #63 of 205 in the Health Care sector. Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $3.28.
Based on SEC 10-K filings.
3.28 in FY2025 with a 5-year CAGR of +13.7%.
Improved from $2.34 to $3.28 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +4.2%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Sector benchmark
#63 of 205 in Health CareTop 31% of 205This company $3.28 Sector average $67.98
▼
-95.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 69.6% year-over-year.
- Ranks #63 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.28 | +69.6% |
| FY2024 | $1.93 | -17.4% |
| FY2023 | $2.34 | -19.3% |
| FY2022 | $2.90 | -20.1% |
| FY2021 | $3.63 | +110.4% |
| FY2020 | $1.72 | +116.6% |
| FY2019 | $0.80 | -33.9% |
| FY2018 | $1.20 | +159.2% |
| FY2017 | $0.46 | -38.3% |
| FY2016 | $0.75 | +366.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026